BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 18549610)

  • 1. [DNA methylation regulates kir3dl1 gene expression in K562 cell line].
    Gao XN; Yu L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Jun; 16(3):472-5. PubMed ID: 18549610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Promoter methylation regulates KIR3DL1 gene expression in NK-92MI cell line].
    Gao XN; Yu L
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Jul; 24(7):668-71. PubMed ID: 18616907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Construction of kir3dl1 promoter expression vector and its activity in K562 cell line].
    Gao XN; Yu L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Apr; 16(2):258-62. PubMed ID: 18426644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Molecular regulation of KIR3DL1 gene expression by transcription factor E2F1].
    Gao XN; Yu L
    Zhonghua Xue Ye Xue Za Zhi; 2008 Dec; 29(12):806-10. PubMed ID: 19176033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. E2F1 contributes to the transcriptional activation of the KIR3DL1 gene.
    Gao XN; Yu L
    Biochem Biophys Res Commun; 2008 Jun; 370(3):399-403. PubMed ID: 18358829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CpG island methylation status in the EpCAM promoter region and gene expression.
    Yu G; Zhang X; Wang H; Rui D; Yin A; Qiu G; He Y
    Oncol Rep; 2008 Nov; 20(5):1061-7. PubMed ID: 18949402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The CpG island promoter of the human proopiomelanocortin gene is methylated in nonexpressing normal tissue and tumors and represses expression.
    Newell-Price J; King P; Clark AJ
    Mol Endocrinol; 2001 Feb; 15(2):338-48. PubMed ID: 11158338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mapping the methylation pattern by bisulfite genomic sequencing of the E-cadherin promoter CpG island in nasopharyngeal carcinoma.
    Kao RH; Huang LC; Hsu YH
    Anticancer Res; 2002; 22(6C):4109-13. PubMed ID: 12553040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of demethylating treatment on cytotoxicity of NK-92MI cells].
    Gao XN; Wang LL; Lin J; Yu L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Aug; 17(4):924-8. PubMed ID: 19698230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expression and Promoter CpG Island Methylation Status of miR-34b in Leukemia Cell Lines and Their Clinical Significance].
    Guo JX; Zhou YH; Guan RT; Pan JX; Zhang XY; Zhong JF
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Oct; 23(5):1235-9. PubMed ID: 26524015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Methylation of CpG island in promoter region of RUNX2 gene and its expression in HOX11(+) acute T lymphoblastic leukemia].
    Jia JS; Salvatore S
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Apr; 21(2):273-8. PubMed ID: 23628015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
    Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
    Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unusual distribution of DNA methylation within the hTERT CpG island in tissues and cell lines.
    Guilleret I; Benhattar J
    Biochem Biophys Res Commun; 2004 Dec; 325(3):1037-43. PubMed ID: 15541393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylation of specific CpG sites in the P2 promoter of parathyroid hormone-related protein determines the invasive potential of breast cancer cell lines.
    Tost J; Hamzaoui H; Busato F; Neyret A; Mourah S; Dupont JM; Bouizar Z
    Epigenetics; 2011 Aug; 6(8):1035-46. PubMed ID: 21775817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammation-induced up-regulation of TLR2 expression in human endothelial cells is independent of differential methylation in the TLR2 promoter CpG island.
    Diesel B; Ripoche N; Risch RT; Tierling S; Walter J; Kiemer AK
    Innate Immun; 2012 Feb; 18(1):112-23. PubMed ID: 21768203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-regulation of interferon regulatory factor 4 gene expression in leukemic cells due to hypermethylation of CpG motifs in the promoter region.
    Ortmann CA; Burchert A; Hölzle K; Nitsche A; Wittig B; Neubauer A; Schmidt M
    Nucleic Acids Res; 2005; 33(21):6895-905. PubMed ID: 16396836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Down-regulation of transcription factor PU.1 via abnormal epigenetic modification in chronic myeloid leukemia].
    Yang H; Yan JS; Tao R; Hao SG; Liang H; Ma LY
    Zhonghua Zhong Liu Za Zhi; 2012 Mar; 34(3):169-75. PubMed ID: 22780968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of human cancer/testis antigen gene, XAGE-1, in tumor cells is correlated with CpG island hypomethylation.
    Lim JH; Kim SP; Gabrielson E; Park YB; Park JW; Kwon TK
    Int J Cancer; 2005 Aug; 116(2):200-6. PubMed ID: 15800911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Methylation status of IEX-1 gene promotor CpG island in malignant hematopoietic cell lines].
    Li XY; Shen JZ; Shen SF; Fu HY; Zhou HR; Wu DS; Zhang YY; Zheng YQ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Apr; 19(2):473-6. PubMed ID: 21518511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA methylation paradigm shift: 15-lipoxygenase-1 upregulation in prostatic intraepithelial neoplasia and prostate cancer by atypical promoter hypermethylation.
    Kelavkar UP; Harya NS; Hutzley J; Bacich DJ; Monzon FA; Chandran U; Dhir R; O'Keefe DS
    Prostaglandins Other Lipid Mediat; 2007 Jan; 82(1-4):185-97. PubMed ID: 17164146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.